These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 2378792)

  • 1. The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.
    Muñoz JJ; De Salamanca RE; Diaz-Obregón C; Timoneda FL
    Br J Clin Pharmacol; 1990 Jun; 29(6):763-5. PubMed ID: 2378792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine intoxication with negative myoclonus after the addition of clobazam.
    Genton P; Nguyen VH; Mesdjian E
    Epilepsia; 1998 Oct; 39(10):1115-8. PubMed ID: 9776334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy.
    Sennoune S; Mesdjian E; Bonneton J; Genton P; Dravet C; Roger J
    Ther Drug Monit; 1992 Aug; 14(4):269-74. PubMed ID: 1519299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
    Liu H; Delgado MR
    Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data.
    van Belle G; Friel PN
    Ther Drug Monit; 1986; 8(2):177-83. PubMed ID: 3726931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M; Riva R; Albani F; Baruzzi AA
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
    Brodie MJ; Forrest G; Rapeport WG
    Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults.
    Lanchote VL; Bonato PS; Campos GM; Rodrigues I
    Ther Drug Monit; 1995 Feb; 17(1):47-52. PubMed ID: 7725376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobazam in the treatment of epilepsy: a review of the literature.
    Remy C
    Epilepsia; 1994; 35 Suppl 5():S88-91. PubMed ID: 8039479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy and polytherapy for intractable epilepsies.
    Cornaggia C; Canevini MP; Giuccioli D; Pinelli P; Pruneri C; Canger R
    Ital J Neurol Sci; 1985 Jun; 6(2):201-5. PubMed ID: 3928525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.
    Jawad S; Richens A; Oxley J
    Br J Clin Pharmacol; 1984 Dec; 18(6):873-7. PubMed ID: 6529527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of additional therapy with zonisamide (Excegran) on protein binding and metabolism of carbamazepine.
    Minami T; Ieiri I; Ohtsubo K; Hirakawa Y; Ueda K; Higuchi S; Aoyama T
    Epilepsia; 1994; 35(5):1023-5. PubMed ID: 7925145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered ratio of carbamazepine-10,11-epoxide/carbamazepine in plasma of children: evidence of anticonvulsant drug interaction.
    Schoeman JF; Elyas AA; Brett EM; Lascelles PT
    Dev Med Child Neurol; 1984 Dec; 26(6):749-55. PubMed ID: 6440824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of the carbamazepine-valproate interaction in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Br J Clin Pharmacol; 1997 Jul; 44(1):21-7. PubMed ID: 9241092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.